ImmunoGen, Inc.
Folate receptor 1 antibodies and immunoconjugates and uses thereof
Last updated:
Abstract:
Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to human folate receptor 1 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
Status:
Grant
Type:
Utility
Filling date:
15 Apr 2019
Issue date:
25 Aug 2020